BNKR — Bankers Investment Trust News Story

0.000.00%

Last trade - 00:00

FinancialsConservativeMid Cap

Market Cap
£1.37bn
Enterprise Value
£1.45bn
Revenue
£230.70m

All News

Bankers Investment - Half-year Report

Bankers Investment Trust

25/06/2025 07:00

RNS Number : 2373O

Bankers Investment Trust PLC

25 June 2025

 

LEGAL ENTITY IDENTIFIER: 213800B9YWXL3X1VMZ69                                                                                   

 

THE BANKERS INVESTMENT TRUST PLC

('the Company')

 

Unaudited results for the half-year ended 30 April 2025

 

This announcement contains regulated information

 

INVESTMENT OBJECTIVE 

Over the long term, the Company aims to achieve capital growth in excess of the FTSE World Index and dividend growth greater than inflation, as measured by the UK Consumer Price Index ('CPI'), by investing in companies listed throughout the world.

 

INVESTMENT POLICY

The following investment ranges apply:

·       Equities: 80% to 100%

·       Debt securities and cash investments: 0% to 20%

·       Investment trusts, collective funds and derivatives: 0% to 15%

 

To achieve an appropriate spread of investment risk the portfolio is broadly diversified by geography, sector and company. The Manager ('Janus Henderson') has the flexibility to invest in any geographic region and any sector with no set limits on individual country or sector exposures and, therefore, the make-up and weighting of the portfolio may differ materially from the FTSE World Index.

 

The Manager primarily employs a bottom-up stock picking investment process, across four regional portfolios, to identify suitable opportunities. While each regional portfolio manager employs their own investment style, they all pay particular regard to cash generation and dividend growth over the medium term.

 

The Company can, but normally does not, invest up to 15% of its gross assets in any other investment companies (including listed investment trusts).

 

Derivatives

The Company may use financial instruments known as derivatives for the purpose of efficient portfolio management while maintaining a level of risk consistent with the risk profile of the Company.

 

Gearing

The Company can borrow to make additional investments with the aim of achieving a return that is greater than the cost of the borrowing. The Company can borrow up to 20% of net assets at the time of draw down.

 

PERFORMANCE HIGHLIGHTS

30 April 2025 30 April 2024
Net asset value ('NAV') per share1 121.5p 125.5p
Share price 109.6p 112.2p
Revenue return per share 1.16p 1.31p
Dividends paid or declared in respect of the period2 1.372p 1.344p

           

Total return performance to 30 April 2025 (including dividends reinvested and excluding transaction costs)

 

6 months
% 1 year
% 3 years
% 5 years
% 10 years
%
NAV1 -4.0 -1.1 14.8 49.3 129.2
Share price3 0.1 0.0 11.5 35.7 118.1
FTSE World Index4 -2.6 5.3 29.5 83.9 144.4

 

 

1 Net asset value total return per share with income reinvested and with debt at fair value, see Note 6 in the Notes to the Condensed Financial Statements

2 The first interim dividend for 2025 was paid on 30 May 2025; the second interim dividend has been declared and will be paid on 29 August 2025

3 Share price total return using mid-market closing price

4 For 10 years, the benchmark is a composite of the FTSE World Index and the FTSE All-Share Index

 

 

Sources: Janus Henderson, Morningstar Direct and LSEG Datastream

INTERIM MANAGEMENT REPORT

 

CHAIR'S STATEMENT

                                                                                                                                        

Dear shareholder,

 

Performance 

The first half of the year has been dominated by the impact on markets of Donald Trump's election. The positive market enthusiasm which accompanied Trump's victory in November had evaporated by early April when he announced a swathe of much higher-than-expected tariffs on all US trading partners. My last statement highlighted that the greatest uncertainty this year would be the outcome of US tariffs. Share prices fell from their peak in February, as the new administration started discussing plans for trade tariffs on imported goods to the US market. Markets do not like uncertainty and investors sold both bonds and equities, forcing down the value of the US dollar. Performance was positive in Europe and Japan where governments are finally tackling slower growth with more reforms and increased spending plans.

 

Your Company has delivered a net asset value total return over the six months ended 30 April 2025 of -4.0% (six months to 30 April 2024: +17.5%) and a share price total return of +0.1% (2024: +21.5%), compared with the FTSE World Index benchmark total return of -2.6% (2024: +16.6%) over the same period. Most of the underperformance in the portfolio happened in November, following a sharp rise in US stocks associated with the new administration's policies. Over the remainder of the period, the portfolio outperformed its benchmark, and this outperformance continued through May. The Fund Manager discusses the key drivers of performance in his report.

 

Revenue and financial statements

Our net revenue for the six months was £12.6 million (2024: £15.9 million), equivalent to 1.16p per share (2024: 1.31p). We expected the reduction in revenue as a result of increasing investment into growth stocks. Companies in the Technology and Healthcare sectors have significant growth opportunities and are prioritising investment spending over dividends. The expectation is that profits will accelerate over time and ultimately lead to higher dividends. In the short term, drawing down on our revenue reserves will allow maintenance of a progressive dividend.

 

A first interim dividend of 0.686p per share (2024: 0.672p) was paid on 30 May 2025. The Board has declared a second interim dividend of 0.686p (2024: 0.672p) per share, an increase of 2.1%, which will be payable on 29 August 2025 to shareholders on the register on 25 July 2025. 

 

The Board's current expectation is that the dividend for the full year will be at least 2% above the total dividend paid in 2024. This modest forecast reflects the current uncertainty in the market's forecasts for corporate profits and therefore dividends. However, it will continue to deliver the Company's progressive dividend policy of successive annual dividend growth which it has achieved every year over the past 58 years. 

 

Discount management

The Company's share price has continued to trade at a discount to its net asset value and we have taken advantage of this opportunity to buy back shares from the market. This activity is beneficial to ongoing shareholders, as shares are only purchased when they are trading at a discount, thereby enhancing shareholder value. 

 

A total of 82,700,048 shares were bought back at an average discount of 10.2% to the net asset value in the six months ended 30 April 2025 (2024: 49,748,991 shares bought back at an average discount of 12.3%) for a total consideration of £97.1 million (2024: £53.4 million). The discount at 30 April 2025 was 9.8% (2024: 10.6%). 

 

Outlook

The hope is that the US will agree a reasonable level of tariffs with key trading partners. However, if the ongoing uncertainty extends through the summer, this will impact growth and ultimately profits. It would be premature to write off the US stock market at this point, given further reforms could well support growth in the economy.

 

 

Simon Miller  

Chair

24 June 2025

 

 

FUND MANAGER'S REPORT                                                                                                               

 

Market Review

The six months to the end of April 2025 was a particularly volatile period for both bond and share prices, encompassing the presidential win by Donald Trump and the subsequent slew of new presidential orders. The US stock market rose by 5% in November, on the back of optimism that Trump would be business friendly, delivering tax cuts and policies to promote growth. This honeymoon period did not last long into the new year before worries started to arise. Markets peaked in February, then fell sharply on concerns about trade tariffs disrupting corporates and creating price inflation for consumers. The unveiling of specific country tariff rates on Liberation Day, in early April, shocked investors and was compounded by the face-off with China with their tariffs rising above 100%. Since then, markets have recaptured much of the fall, with hopes that pragmatism will prevail.

 

The US has called on other nations to raise their defence spending, which has spurred Germany to significantly raise investment spending on defence and energy. The promise of higher spending in Europe has supported their stock markets, although the real effect on GDP growth will be a few years into the future. Japan also performed well, as the currency strengthened and interest rates increased, supporting large sectors of the market like banks.

 

The policy uncertainty has driven a fear of recession, but corporate results delivered broadly in line with forecasts. While estimates for this year's growth have been reduced, most commentators are still predicting economic and corporate profit growth for all regions. 

 

Performance

The portfolio underperformed the benchmark during November due to lower exposure to the US market than the index and underperformance of stock selection in the US market. Since November, the asset allocation has been more favourable and stock selection has improved, although we were unable to make up all the underperformance. The best regions in absolute terms have been Europe and Japan: both rose by 5.5% in Sterling terms during the period. The Japanese stocks outperformed their benchmark index by 3%, driven predominantly by financials but Sony also put in a good performance, driven by high expectations on the gaming side of the business.

 

Financials generally were the largest positive contributor to relative performance. Banks have performed well as earnings are supported by interest rate hedging and expanding loan books, while cost pressure is easing through new digital offerings. Technology also performed well, driven by ongoing AI optimism although performance faded in the technology hardware sector on worries about tariffs. Healthcare and retail sectors held back performance. Valuations in the healthcare sector fell on concerns about pricing, tariffs and drug patent expiries. In the consumer sectors, rising prices have caused shoppers to prioritise their spending and to favour better value offerings, hitting margins.

 

Portfolio

The portfolio's allocation to the US market was increased following the US presidential election as the market friendly Republican party claimed the victory. Even with the allocation to the US market peaking at 63%, it remained below the benchmark's US allocation. Over the remaining months we have used the US market as a source of cash to fund the share buybacks, reducing the allocation to 60% by the period end. Gearing has been maintained at around 5% during the period, as we made sure that we were positioned for a bounce in markets. The portfolio is overweight Europe and Japan relative to the benchmark, as we feel valuations are more appealing, combined with less exposure to the challenges of rising trade tariffs.

 

Outlook

It is notable that share prices have recovered most of their fall this year despite any real certainty on trade negotiations between the US and their trading partners. Bringing manufacturing back to the US is likely to be impractical in some key sectors like textiles and is certain to depress margins in sectors like pharmaceuticals and technology. If tariffs end up in the 10% to 20% range, then the market is likely to move its focus to the more business friendly policies in the US, such as tax reforms and deregulation. Elsewhere in the world, economic growth is recovering from last year's slowdown and interest rate cuts are supporting easier monetary conditions. Valuations are lower than the US and may improve as confidence in growth increases.

 

 

Alex Crooke

Fund Manager 

24 June 2025

 

 

MANAGING OUR RISKS
The principal and emerging risks and uncertainties associated with the Company's business are divided into the following main areas:
· Investment Activity and Performance Risks
· Portfolio and Market Risks
· Tax, Legal, Regulatory and Governance Risks
· Financial Risks
· Operational and Cyber Risks
· Risks associated with Climate Change
Information on these risks and uncertainties and how they are managed are given in the Annual Reportfor the year ended 31 October 2024. Following a recent review, the Board has amended Tax, Legal and Regulatory Risk to include Governance. All other principal and emerging risks at the year-end remain and are as applicable to the remaining six months of the financial year as they were to the six months under review.
DIRECTORS' RESPONSIBILITY STATEMENT
The Directors (listed in note 14) confirm that, to the best of their knowledge:
(a) the unaudited condensed set of financial statements has been prepared in accordance with IAS 34 - Interim Financial Reporting ('IAS 34') and gives a true and fair view of the assets, liabilities, financial position and profit or loss of the Company as required by Disclosure Guidance and Transparency Rule 4.2.4R;
(b) the interim management report includes a fair review of the information required by Disclosure Guidance and Transparency Rule 4.2.7R (indication of important events during the first six months and description of principal risks and uncertainties for the remaining six months of the year); and
(c) the interim management report includes a fair review of the information required by Disclosure Guidance and Transparency Rule 4.2.8R (disclosure of related party transactions that have taken place in the first six months of the current financial year and that have materially affected the financial position or the performance of the Company during the period; and any changes in related party transactions described in the latest annual report that could have an impact in the first six months of the current financial year).

 On behalf of the Board

 Simon Miller

 Chair

 24 June 2025

 

 

 

For further information contact: 

                                   

Alex Crooke
Fund Manager
The Bankers Investment Trust PLC
Telephone: 020 7818 4447 Simon Miller
Chair
The Bankers Investment Trust PLC
Telephone: 020 7818 1818
Dan Howe
Head of Investment Trusts
Janus Henderson Investors
Telephone: 020 7818 1818 Harriet Hall
PR Director, Investment Trusts
Janus Henderson Investors
Telephone: 020 7818 2636

 

CONDENSED STATEMENT OF COMPREHENSIVE INCOME



(Unaudited)
Half-year ended
30 April 2025 (Unaudited)
Half-year ended
30 April 2024 (Audited)
Year ended
31 October 2024
Revenue return £'000 Capital return £'000 Total £'000 Revenue return £'000 Capital return £'000 Total £'000 Revenue return £'000 Capital return £'000 Total
£'000
(Losses)/gains on investments held at fair value through profit or loss - (70,740) (70,740) - 177,057 177,057 - 205,394 205,394
Investment income 16,080 - 16,080 19,107 - 19,107 37,652 - 37,652
Other operating income 536 - 536 567 - 567 1,003 - 1,003
--------- ----------- --------- --------- ----------- --------- ----------- ----------- -----------
Gross revenue and capital (losses)/gains 16,616 (70,740) (54,124) 19,674 177,057 196,731 38,655 205,394 244,049
---------- ------------ ----------- ---------- ----------- ----------- ----------- ----------- -----------
Expenses 
Management fees (note 2) (900) (2,099) (2,999) (910) (2,123) (3,033) (1,856) (4,334) (6,190)
Other expenses (777) - (777) (642) - (642) (1,329) - (1,329)
--------- ----------- --------- --------- ----------- --------- --------- --------- ---------
Profit/(loss) before finance costs and taxation 14,939 (72,839) (57,900) 18,122 174,934 193,056 35,470 201,060 236,530
Finance costs (491) (1,145) (1,636) (519) (1,151) (1,670) (998) (2,329) (3,327)
--------- ----------- --------- --------- ----------- --------- --------- ----------- -----------
Profit/(loss) before taxation 14,448 (73,984) (59,536) 17,603 173,783 191,386 34,472 198,731 233,203
--------- ---------- --------- --------- ---------- --------- --------- ---------- ---------
Taxation (1,859) (133) (1,992) (1,662) (59) (1,721) (3,194) (59) (3,253)
--------- ----------- --------- --------- ----------- --------- --------- ---------- ---------
Profit/(loss) for the period 12,589 (74,117) (61,528) 15,941 173,724 189,665 31,278 198,672 229,950
===== ====== ====== ===== ====== ====== ====== ====== ======
Earnings/(loss) per ordinary share(note 3) 1.16p (6.83p) (5.67p) 1.31p 14.31p 15.62p 2.63p 16.70p 19.33p
===== ====== ====== ===== ====== ====== ====== ====== ======

 

 

The total columns of this statement represent the Statement of Comprehensive Income, prepared in accordance with UK adopted international accounting standards. The revenue return and capital return columns are supplementary to this and are prepared under guidance published by the Association of Investment Companies. 

 

All income is attributable to the equity shareholders of The Bankers Investment Trust PLC.

 

The accompanying condensed notes are an integral part of the financial statements.

 

 

 

CONDENSED STATEMENT OF CHANGES IN EQUITY                                                                                                                                                                                                                                     

Half-year ended 30 April 2025 (Unaudited) Called up
share capital
£'000 Share premium
account
£'000 Capital redemption
reserve
£'000 Other capital reserves
£'000 Revenue reserve
£'000 Total
£'000
Total equity at 1 November 2024 32,878 159,797 12,489 1,186,189 42,793 1,434,146
Total comprehensive income: 
- Loss for the period - - - (74,117) 12,589 (61,528)
Transactions with owners, recorded
directly to equity: 
- Buy-back of shares to treasury (note 5) - - - (97,117) - (97,117)
- Ordinary dividends paid (note 11) - - - - (15,203) (15,203)
---------- ---------- ---------- ------------- ---------- --------------
Total equity at
 30 April 2025 32,878 159,797 12,489 1,014,955 40,179 1,260,298
====== ====== ====== ======== ====== ========
Half-year ended 30 April 2024 (Unaudited) Called up
share capital
£'000 Share
premium
account
£'000 Capital redemption
reserve
£'000 Other capital
reserves
£'000 Revenue reserve
£'000 Total
£'000
Total equity at 1 November 2023 32,878 159,797 12,489 1,084,848 43,511 1,333,523
Total comprehensive income: 
- Profit for the period - - - 173,724 15,941 189,665
Transactions with owners, recorded
directly to equity: 
- Buy-back of shares to treasury (note 5) - - - (53,389) - (53,389)
- Ordinary dividends paid (note 11) - - - - (16,205) (16,205)
---------- ---------- ---------- ------------- ---------- --------------
Total equity at 30 April 2024 32,878 159,797 12,489 1,205,183 43,247 1,453,594
====== ====== ====== ======== ====== ========
Year ended 31 October 2024 (Audited) Called up
share capital
£'000 Share premium
account
£'000 Capital redemption
reserve £'000 Other capital
reserves
£'000 Revenue reserve
£'000 Total
£'000
Total equity at 1 November 2023 32,878 159,797 12,489 1,084,848 43,511 1,333,523
Total comprehensive income: 
- Profit for the year - - - 198,672 31,278 229,950
Transactions with owners, recorded directly to equity: 
- Buy-back of shares to treasury (note 5) - - - (97,331) (97,331)
- Ordinary dividends paid (note 11) - - - - (31,996) (31,996)
---------- ---------- ----------- ------------- ---------- -------------
Total equity at 31 October 2024 32,878 159,797 12,489 1,186,189 42,793 1,434,146
====== ====== ====== ======== ====== ========


 

The accompanying condensed notes are an integral part of the financial statements.

CONDENSED STATEMENT OF FINANCIAL POSITION

(Unaudited)
As at 30 April
2025
£'000 (Unaudited)
As at 30 April
2024
£'000 (Audited)
As at 31 October
2024
£'000
Non-current assets 
Investments held at fair value through profit or loss 1,320,427 1,530,994 1,455,333
------------- ------------- -------------
Current assets 
Investments held at fair value through profit or loss (note 4) 23,962 21,509 33,549
Other receivables 4,658 7,128 4,646
Cash and cash equivalents 39,175 28,726 66,689
-------------- -------------- --------------
67,795 57,363 104,884
-------------- -------------- --------------
Total assets 1,388,222 1,588,357 1,560,217
-------------- -------------- --------------
Current liabilities 
Other payables (3,867) (10,604) (2,315)
-------------- -------------- --------------
(3,867) (10,604) (2,315)
-------------- -------------- --------------
Total assets less current liabilities 1,384,355 1,577,753 1,557,902
-------------- -------------- --------------
Non-current liabilities 
Unsecured loan notes (124,057) (124,159) (123,756)
-------------- -------------- --------------
Net assets 1,260,298 1,453,594 1,434,146
======== ======== ========
Equity attributable to equity shareholders 
Share capital (note 5) 32,878 32,878 32,878
Share premium account 159,797 159,797 159,797
Capital redemption reserve 12,489 12,489 12,489
Retained earnings: 
Other capital reserves 1,014,955 1,205,183 1,186,189
Revenue reserve 40,179 43,247 42,793
-------------- -------------- --------------
Total equity 1,260,298 1,453,594 1,434,146
======== ======== ========
Net asset value per ordinary share(note 6) 118.5p 122.7p 125.2p
====== ====== ======


 

The accompanying condensed notes are an integral part of the financial statements.

 

 

 

CONDENSED CASH FLOW STATEMENT

Reconciliation of profit before taxation to net cash flow
from operating activities (Unaudited)
Half-year ended
30 April
2025
£'000 (Unaudited)
Half-year ended
30 April
2024
£'000 Restated1 (Audited)
Year ended
31 October
2024
£'000
Operating activities 
(Loss)/profit before taxation (59,536) 191,386 233,203
Less: loss/(gain) on investments held at fair value through profit or loss 70,740 (177,057) (205,394)
Purchases of investments (458,000) (353,778) (1,013,738)
Sales of investments 524,303 428,187 1,191,430
Purchases of current asset investments (93,533) (49,907) (117,393)
Sales of current asset investments 103,120 41,514 96,959
Increase/(decrease) in securities purchased for future settlement 632 13,540 (13,721)
(Increase)/decrease in securities sold for future settlement - (6,271) 13,559
(Increase)/decrease in other receivables (30) (32) 32
Increase/(decrease) in other payables 73 (104) (94)
Decrease/(increase) in accrued income 65 (1,651) 502
Add back interest payable ('finance costs') 1,636 1,670 3,327
------------ ------------ ------------
Net cash inflow from operating activities
before interest and taxation 89,470 87,497 188,672
Interest paid (1,664) (2,438) (3,359)
Taxation paid (2,038) (1,706) (2,932)
------------ ------------ ------------
Net cash inflow from operating activities 85,768 83,353 182,381
======= ======= =======
Financing activities 
Equity dividends paid (15,203) (16,205) (31,996)
Share buy-backs (96,244) (53,389) (98,207)
------------ ------------ ------------
Net cash outflow from financing activities (111,447) (69,594) (130,203)
======= ======= =======
(Decrease)/increase in cash (25,679) 13,759 52,178
Cash and cash equivalents at the start of the period 66,689 14,525 14,525
Exchange movements (1,835) 442 (14)
----------- ----------- ------------
Cash and cash equivalents at the end of the period 39,175 28,726 66,689
======= ======= =======

 

1Prior year comparatives have been restated as explained further in note 1.

 

The accompanying condensed notes are an integral part of the financial statements.

 

 

 

NOTES TO THE CONDENSED FINANCIAL STATEMENTS:

 

1. Accounting policies
The Bankers Investment Trust PLC ('the Company') is a company incorporated and domiciled in the United Kingdom under the Companies Act 2006.
These condensed financial statements comprise the unaudited results of the Company for the half-year ended 30 April 2025. They have been prepared on a going concern basis and in accordance with UK adopted international accounting standards and with the Statement of Recommended Practice for Investment Trusts ('SORP') dated July 2022, where the SORP is consistent with the requirements of UK adopted international accounting standards.
For the period under review, the Company's accounting policies have not varied in any material way from those described in the Annual Report for the year ended 31 October 2024.
These financial statements have not been either audited or reviewed by the Company's Auditor.
Restatement of Cash Flow Statement
Following publication of the annual financial statements for the year ended 31 October 2024, an error was identified in the cash flow statement whereby the cash balance did not agree to the Statement of Financial Position. This error was primarily due to an omission of a line item in the cash flow statement relating to the movement in 'securities sold for future settlement' and additionally a classification error in relation to 'interest paid'. These matters resulted in the value of the 'Cash and cash equivalents at the end of the year' being incorrect. The error did not impact the Statement of Comprehensive Income, Statement of Changes in Equity or the Statement of Financial Position, where the correct cash position was presented, nor did it impact earnings per share or the net asset value per share.
The comparative figures in the Cash Flow Statement for the year ended 31 October 2024 have therefore been restated to correct these errors and the following corrections have been made, which include corrections to a number of the sub-totals within the statement:
Cash flow line item As previously reported
£'000 As restated
£'000 Impact on line
£'000
(Increase)/decrease in securities sold for future settlement - 13,559 13,559
Net cash inflow from operating activities before interest and taxation (sub-total) 175,113 188,672 13,559
Interest paid (4,506) (3,359) 1,147
Net cash flow from operating activities (sub-total) 167,675 182,381 14,706
(Decrease)/increase in cash (sub-total) 37,472 52,178 14,706
Cash and cash equivalents 51,983 66,689 14,706
2. Management fees
(Unaudited) (Unaudited) (Audited)
Half-year ended
30 April 2025 Half-year ended
30 April 2024 Year ended
31 October 2024
Revenue return
£'000 Capital return
£'000 Total
£'000 Revenue
return
£'000 Capital return
£'000 Total
£'000 Revenue return
£'000 Capital return
£'000 Total
£'000
Investment management 900 2,099 2,999 910 2,123 3,033 1,856 4,334 6,190
===== ===== ===== ===== ===== ===== ===== ===== =====
3. Earnings per ordinary share
The earnings per ordinary share figure is based on the net loss for the half-year of £61,528,000 (30 April 2024: net profit of £189,665,000; 31 October 2024: net profit of £229,950,000) and on 1,085,471,866 (30 April 2024: 1,214,507,013; 31 October 2024: 1,189,599,929) ordinary shares, being the weighted average number of ordinary shares in issue excluding treasury shares during the period.
The return per share detailed above can be further analysed between revenue and capital, as below.
(Unaudited)
Half-year ended
30 April 2025
£'000 (Unaudited)
Half-year ended
30 April 2024
£'000 (Audited)
Year ended
31 October 2024
£'000
Revenue profit 12,589 15,941 31,278
Capital (loss)/profit (74,117) 173,724 198,672
------------ ------------ -----------
Total (loss)/profit (61,528) 189,665 229,950
======= ======= =======
Weighted average number of ordinary shares
in issue during each period 1,085,471,866 1,214,507,013 1,189,599,929
Revenue earnings per ordinary share 1.16p 1.31p 2.63p
Capital (loss)/earnings per ordinary share (6.83p) 14.31p 16.70p
------------ ------------ -----------
Total (loss)/earnings per ordinary share (5.67p) 15.62p 19.33p
======= ======= =======


 

4. Current asset investment
The Company has a holding in the Deutsche Bank Global Liquidity Series Fund, a money market fund which is viewed as a readily disposable store of value and which is used to invest cash balances that would otherwise be placed on short-term deposit. At 30 April 2025 this holding had a value of £23,962,000 (30 April 2024: £21,509,000; 31 October 2024: £33,549,000).
5. Share capital
At 30 April 2025 there were 1,315,102,830 ordinary shares of 2.5p each in issue of which 251,912,008 were held in treasury (with no voting rights) (30 April 2024: 1,315,102,830 of which 130,619,544 were held in treasury; 31 October 2024: 1,315,102,830 of which 169,211,960 were held in treasury). During the half-year ended 30 April 2025, 82,700,048 shares were bought back into treasury at a total cost of £97,117,000 (half year to 30 April 2024: 49,748,991 shares were bought back into treasury at a total cost of £53,389,000; year to 31 October 2024: 88,341,407 shares were bought back in to treasury for a total cost of £97,331,000). Since the period end to 24 June 2025, the Company has bought back 16,648,525 shares for treasury for a total cost of £19,467,000.
6. Net asset value per ordinary share
The net asset value per ordinary share is based on the net assets attributable to equity shareholders of £1,260,298,000 (30 April 2024: £1,453,594,000; 31 October 2024: £1,434,146,000) and on 1,063,190,822 (30 April 2024: 1,184,483,286; 31 October 2024: 1,145,890,870) ordinary shares, being the number of ordinary shares in issue with voting rights at the period end.
The following table reconciles from the NAV with debt at par to the NAV with debt at fair value.
Net asset value ("NAV") with debt at par and at fair value
30 April 2025 30 April 2024 31 Oct 2024
£'000 £'000 £'000
NAV with debt at par (A) 1,260,298 1,453,594 1,434,146
Add back par value of loan notes 124,057 124,159 123,756
Less fair value of loan notes (92,324) (91,757) (92,618)
NAV with debt at fair value (B) 1,292,031 1,485,996 1,465,284
Ordinary shares in issue (C) 1,063,190,822 1,184,483,286 1,145,890,870
NAV per ordinary share with debt at par
(A/C x 100) (pence) 118.5 122.7 125.2
NAV per ordinary share with debt at fair value (B/C x 100) (pence) 121.5 125.5 127.9
7. Related party transactions
The Company's transactions with related parties during the period were with its Directors and Janus Henderson. There have been no material transactions between the Company and its Directors during the period other than the amounts paid to them in respect of Directors' remuneration for which there were no outstanding amounts payable at the period end.
In relation to the provision of services by Janus Henderson, other than fees payable by the Company in the ordinary course of business and the provision of marketing services, there have been no transactions with Janus Henderson affecting the financial position or performance of the Company during the period under review.
8. Financial instruments
At the period end the carrying value of financial assets approximates their fair value.
Financial instruments carried at fair value
Fair value hierarchy
The unsecured loan notes are valued at par in the Statement of Financial Position.
The fair value of the loan notes at 30 April 2025 has been estimated to be £92,324,000 (30 April 2024: £91,757,000; 31 October 2024: £92,618,000) and is categorised as level 3 in the fair value hierarchy as described below. This has been reflected in the daily NAV announcements since January 2024. Previously the unsecured loan notes were valued at amortised cost in the fair value NAV.
The following table analyses recurring fair value measurements for financial assets. These fair value measurements are categorised into different levels in the fair value hierarchy based on the inputs to valuation techniques used.
Financial assets at fair value through profit or loss at 30 April 2025 (Unaudited) Level 1
£'000 Level 2
£'000 Level 3
£'000 Total
£'000
Investments including derivatives: 
- Equity investments 1,320,427 - - 1,320,427
- Fixed interest investments - - - -
- Current asset investments 23,962 - - 23,962
-------------- --------- -------- --------------
Total financial assets carried at fair value 1,344,389 - - 1,344,389
======== ===== ===== ========
Financial assets at fair value through profit or loss at 30 April 2024 (Unaudited) Level 1
£'000 Level 2
£'000 Level 3
£'000 Total
£'000
Investments including derivatives: 
- Equity investments 1,530,994 - - 1,530,994
- Fixed interest investments - - - -
- Current asset investments 21,509 - - 21,509
-------------- --------- -------- --------------
Total financial assets carried at fair value 1,552,503 - - 1,552,503
======== ===== ==== ========
Financial assets at fair value through profit or loss at 31 October 2024 (Unaudited) Level 1
£'000 Level 2
£'000 Level 3
£'000 Total
£'000
Investments including derivatives: 
- Equity investments 1,455,333 - - 1,455,333
- Fixed interest investments - - - -
- Current asset investments 33,549 - - 33,549
-------------- --------- -------- --------------
Total financial assets carried at fair value 1,488,882 - - 1,488,882
======== ===== ==== ========


 

9. Reconciliation of liabilities arising from financing activities
Non-cash changes
At
1 November
2024
£'000 Cash
flows
£'000 Amortisation
of issue costs
£'000 Foreign
exchange
£'000 At 30 April
2025
£'000
Financing activities 
Financing liabilities 123,756 - 10 291 124,057
Closing liabilities from financing activities -----------
123,756
====== -----------
-
====== -----------
10
====== -----------
291
====== -----------
124,057
======
Non-cash changes
At
1 November
2023
£'000 Cash
flows
£'000 Amortisation
of issue costs
£'000 Foreign
exchange
£'000 At 30 April
2024
£'000
Financing activities 
Financing liabilities 124,900 - 14 (755) 124,159
Closing liabilities from financing activities ----------
124,900
====== ---------
-
====== ---------
14
====== ---------
(755)
====== ----------
124,159
======
Non-cash changes
At
1 November
2023
£'000 Cash
flows
£'000 Amortisation
of issue costs
£'000 Foreign
exchange
£'000 At 31 October
2024
£'000
Financing activities 
Financing liabilities 124,900 - 26 (1,170) 123,756
Closing liabilities from financing activities -----------
124,900
====== ---------
-
====== -----------
26
====== -----------
(1,170)
====== -----------
123,756
======
10. Going concern
In assessing the Company's going concern, the Directors have considered among other things, cash flow forecasts, a review of covenant compliance including the headroom above the most restrictive covenants and an assessment of the liquidity of the portfolio and the impact of the war in Ukraine and Israel and changes in the international political landscape. The assets of the Company consist mainly of securities that are listed and readily realisable. Thus, after making due enquiry, the Directors believe that the Company has adequate financial resources to meet its financial obligations, including the repayment of any borrowings, and to continue in operational existence for at least 12 months from the date of approval of the financial statements. Accordingly, the Directors continue to adopt the going concern basis in preparing the financial statements.
11. Dividends
A first interim dividend of 0.686p (2024: 0.672p) per ordinary share, was paid on 30 May 2025 to shareholders registered on 25 April 2025. The shares were quoted ex-dividend on 24 April 2025. Based on the number of ordinary shares in issue at 25 April 2025 (excluding shares held in treasury) of 1,064,854,738 the cost of this dividend was £7,305,000.
The Directors have declared a second interim dividend of 0.686p (2024: 0.672p) per ordinary share which will be payable on 29 August 2025 to shareholders on the register on 25 July 2025. The shares will be quoted ex-dividend on 24 July 2025. Based on the number of shares in issue, excluding shares held in treasury, at 24 June 2025 of 1,046,542,297 the cost of this dividend will be £7,179,000.
12. Comparative information
The financial information contained in this half-year report does not constitute statutory accounts as defined in Section 434 of the Companies Act 2006. The financial information for the half-years ended 30 April 2025 and 2024 have not been audited or reviewed by the Auditor.
The figures and financial information for the year ended 31 October 2024 have been extracted from the latest published financial statements of the Company. These financial statements have been delivered to the Registrar of Companies and included the report of the Auditor which was unqualified and did not contain a statement under either section 498(2) or 498(3) of the Companies Act 2006. A glossary of terms and details of alternative performance measures can be found in the Annual Report for the year ended 31 October 2024.
13. Half-year report
The half-year report will be available on the Company's website (www.bankersinvestmenttrust.com) or in hard copy from the Company's registered office. An abbreviated version of this half-year report, the 'Update', will be circulated to shareholders in early July 2025.
14. General information
Company status
The Company is a UK domiciled investment trust company.
London Stock Exchange Daily Official List (SEDOL): BN4NDR3 / ISIN number: GB00BN4NDR39
London Stock Exchange (TIDM) Code: BNKR
New Zealand Stock Exchange Code: BIT
Global Intermediary Identification Number (GIIN): L5YVFP.99999.SL.826
Legal Entity Identifier (LEI): 213800B9YWXL3X1VMZ69
Registered Office
201 Bishopsgate, London EC2M 3AE
Company Registration Number
UK: 00026351
NZ: 645360
Directors
The Directors of the Company are Simon Miller (Chair), Richard West (Senior Independent Director), Ankush Nandra (Audit & Risk Assurance Committee Chair), Hannah Philp (Marketing Committee Chair) and Charlotte Valeur.
Corporate Secretary
Janus Henderson Secretarial Services UK Limited.
Website
Details of the Company's share price and net asset value, together with general information about the Company, monthly factsheets and data, copies of announcements, reports and details of general meetings can be found atwww.bankersinvestmenttrust.com.


 

50 Largest Investments

At 30 April 2025



Rank
30 Apr 2025 Rank
31 Oct 2024 Company Country Valuation
 31 Oct
2024
£'000 Purchases
£'000 Sales proceeds
£'000 Appreciation/
 (depreciation)
£'000 Valuation
 30 Apr
2025
£'000 
1 1 Microsoft US 65,307 16,451 (9,586) (6,377) 65,795 
2 5 Alphabet US 27,066 19,084 (1,683) (5,821) 38,646 
3 4 Broadcom US 28,032 9,158 (1,463) 2,867 38,594 
4 3 Amazon US 35,436 10,568 (6,413) (2,614) 36,977 
5 2 Apple US 46,595 12,592 (18,723) (4,842) 35,622 
6 11 Meta US 23,260 12,931 (3,585) (2,946) 29,660 
7 29 Eli Lilly US 17,064 10,956 (1,080) 1,234 28,174 
8 6 KLA Corp US 26,961 5,667 (5,792) 522 27,358 
9 8 Visa US 25,759 6,978 (9,773) 3,869 26,833 
10 10 American Express US 23,729 6,701 (2,086) (2,227) 26,117 
11 40 Philip Morris International US 14,707 7,396 (1,316) 5,243 26,030 
12 21 Morgan Stanley US 19,775 7,561 (1,333) (1,408) 24,595 
13 43 Amphenol US 14,164 6,470 (765) 1,499 21,368 
14 # JPMorgan Chase US - 23,520 (945) (1,626) 20,949 
15 12 Chevron US 22,799 6,182 (5,958) (2,866) 20,157 
16 # Intuit US 9,968 11,354 (894) (712) 19,716 
17 14 Siemens Germany 22,118 - (5,308) 2,794 19,604 
18 36 Johnson & Johnson US 15,622 5,551 (1,026) (1,083) 19,064 
19 24 Deutsche Boerse Germany 18,149 - (4,180) 4,772 18,741 
20 27 Prologis US 17,850 4,585 (1,187) (2,903) 18,345 
21 7 CME US 26,908 7,276 (20,132) 3,569 17,621 
22 41 Verizon Communications US 14,696 6,587 (3,455) (221) 17,607 
23 18 National Grid UK 20,462 - (4,595) 1,736 17,603 
24 44 Raytheon Technologies US 13,998 3,878 (682) 80 17,274 
25 31 NatWest UK 16,742 - (4,181) 4,321 16,882 
26 34 Marriott International US 16,018 5,862 (2,950) (2,849) 16,081 
27 39 Stryker US 14,718 2,376 (1,465) 34 15,663 
28 # Booz Allen Hamilton US 10,756 11,323 (603) (5,944) 15,532 
29 28 Accenture US 17,249 7,620 (7,179) (2,310) 15,380 
Rank
30 Apr 2025 Rank
31 Oct 2024 Company Country Valuation
 31 Oct
2024
£'000 Purchases
£'000 Sales proceeds
£'000 Appreciation/
 (depreciation)
£'000 Valuation
 30 Apr
2025
£'000
30 # Walt Disney US - 20,126 (601) (4,197) 15,328
31 # Progressive US - 14,450 (635) 1,366 15,181
32 # Eaton US 10,586 7,810 (435) (2,792) 15,169
33 22 UniCredit Italy 18,904 - (7,181) 3,176 14,899
34 # Dell Technologies US 7,303 14,634 (580) (6,597) 14,760
35 25 Oracle US 18,142 5,593 (4,679) (4,328) 14,728
36 33 Roche Switzerland 16,287 1,890 (3,453) (86) 14,638
37 19 SGS Switzerland 20,297 - (3,818) (1,983) 14,496
38 9 UnitedHealth US 25,474 3,887 (7,972) (6,919) 14,470
39 15 Compass UK 21,843 - (8,503) 791 14,131
40 # Salesforce US - 18,037 (643) (3,558) 13,836
41 20 TotalEnergies France 19,844 - (4,148) (1,871) 13,825
42 # Trane Technologies US 9,275 5,518 (532) (500) 13,761
43 26 Hermès France 18,123 - (7,482) 3,003 13,644
44 # Union Pacific US - 16,698 (531) (2,942) 13,225
45 42 Safran France 14,233 - (3,429) 1,631 12,435
46 35 Sanofi France 15,978 - (3,342) (301) 12,335
47 # Vertex Pharmaceuticals US 11,013 4,571 (3,897) 515 12,202
48 # Sony Japan 11,814 439 (4,681) 4,538 12,110
49 32 Informa UK 16,585 - (3,896) (1,129) 11,560
50 48 SAP Germany 12,324 - (3,039) 2,184 11,469
893,933 342,280 (201,815) (34,208) 1,000,190

 

All securities are equity investments

# Not in top 50 at 31 October 2024

Convertibles and all classes of equity in any one company are treated as one investment

 

 



 

Revenue Generated 
30 April 2025
£million 30 April 2024
£million
North America 7.6 5.6
Pan Europe 4.4 7.9
Pan Asia 2.2 3.1
Japan 1.9 2.2
Emerging Markets - 0.3
--------- ---------
16.1 19.1
===== =====
Comparatives for 30 April 2024 have been restated for the change in portfolio sleeve. UK has been included in Pan Europe and China has been included in Pan Asia.
Source: Janus Henderson 
Regional Breakdown
Equities excluding cash held Valuation of investments
30 April 2025
% 31 October 2024
%
North America 59.9 49.6
Pan Europe 21.0 25.6
Japan 11.5 13.5
Pan Asia 7.6 11.3
--------- ---------
100.0 100.0
===== =====
Source: Janus Henderson 
Sector Breakdown
As a percentage of the investment portfolio excluding cash
30 April 2025
% 31 October 2024
%
Technology 29.7 27.0
Industrials 18.0 16.4
Financials 16.1 15.0
Consumer Discretionary 12.3 12.4
Healthcare 9.9 13.1
Consumer Staples 4.8 5.1
Energy 3.0 3.4
Real Estate 2.3 2.4
Utilities 1.7 3.1
Telecommunications 1.3 1.3
Basic Materials 0.9 0.8
--------- ---------
100.0 100.0
===== =====
Source: Janus Henderson 
Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) are incorporated into, or forms part of, this announcement.
*********************************

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
IR FLFSERVISFIE

BNKR — Bankers Investment Trust News Story

Bankers Investment - Half-year Report

Recent news on Bankers Investment Trust

Bankers Investment - Director/PDMR Shareholding

Bankers Investment - Director/PDMR Shareholding

Bankers Investment - Director/PDMR Shareholding

Bankers Investment - Half-year Financial Report

Bankers Investment - Director/PDMR Shareholding

	30 April 2025	30 April 2024
Net asset value ('NAV') per share1	121.5p	125.5p
Share price	109.6p	112.2p
Revenue return per share	1.16p	1.31p
Dividends paid or declared in respect of the period2	1.372p	1.344p

	6 months %	1 year %	3 years %	5 years %	10 years %
NAV1	-4.0	-1.1	14.8	49.3	129.2
Share price3	0.1	0.0	11.5	35.7	118.1
FTSE World Index4	-2.6	5.3	29.5	83.9	144.4

MANAGING OUR RISKS
The principal and emerging risks and uncertainties associated with the Company's business are divided into the following main areas:
· Investment Activity and Performance Risks · Portfolio and Market Risks · Tax, Legal, Regulatory and Governance Risks · Financial Risks · Operational and Cyber Risks · Risks associated with Climate Change

Information on these risks and uncertainties and how they are managed are given in the Annual Reportfor the year ended 31 October 2024. Following a recent review, the Board has amended Tax, Legal and Regulatory Risk to include Governance. All other principal and emerging risks at the year-end remain and are as applicable to the remaining six months of the financial year as they were to the six months under review.

DIRECTORS' RESPONSIBILITY STATEMENT
The Directors (listed in note 14) confirm that, to the best of their knowledge:

(a)	the unaudited condensed set of financial statements has been prepared in accordance with IAS 34 - Interim Financial Reporting ('IAS 34') and gives a true and fair view of the assets, liabilities, financial position and profit or loss of the Company as required by Disclosure Guidance and Transparency Rule 4.2.4R;
(b)	the interim management report includes a fair review of the information required by Disclosure Guidance and Transparency Rule 4.2.7R (indication of important events during the first six months and description of principal risks and uncertainties for the remaining six months of the year); and

(c)	the interim management report includes a fair review of the information required by Disclosure Guidance and Transparency Rule 4.2.8R (disclosure of related party transactions that have taken place in the first six months of the current financial year and that have materially affected the financial position or the performance of the Company during the period; and any changes in related party transactions described in the latest annual report that could have an impact in the first six months of the current financial year).

Alex Crooke Fund Manager The Bankers Investment Trust PLC Telephone: 020 7818 4447	Simon Miller Chair The Bankers Investment Trust PLC Telephone: 020 7818 1818
Dan Howe Head of Investment Trusts Janus Henderson Investors Telephone: 020 7818 1818	Harriet Hall PR Director, Investment Trusts Janus Henderson Investors Telephone: 020 7818 2636

	(Unaudited) Half-year ended 30 April 2025			(Unaudited) Half-year ended 30 April 2024			(Audited) Year ended 31 October 2024
	Revenue return £'000	Capital return £'000	Total £'000	Revenue return £'000	Capital return £'000	Total £'000	Revenue return £'000	Capital return £'000	Total £'000
(Losses)/gains on investments held at fair value through profit or loss	-	(70,740)	(70,740)	-	177,057	177,057	-	205,394	205,394
Investment income	16,080	-	16,080	19,107	-	19,107	37,652	-	37,652
Other operating income	536	-	536	567	-	567	1,003	-	1,003
	---------	-----------	---------	---------	-----------	---------	-----------	-----------	-----------
Gross revenue and capital (losses)/gains	16,616	(70,740)	(54,124)	19,674	177,057	196,731	38,655	205,394	244,049
	----------	------------	-----------	----------	-----------	-----------	-----------	-----------	-----------
Expenses
Management fees (note 2)	(900)	(2,099)	(2,999)	(910)	(2,123)	(3,033)	(1,856)	(4,334)	(6,190)
Other expenses	(777)	-	(777)	(642)	-	(642)	(1,329)	-	(1,329)
	---------	-----------	---------	---------	-----------	---------	---------	---------	---------
Profit/(loss) before finance costs and taxation	14,939	(72,839)	(57,900)	18,122	174,934	193,056	35,470	201,060	236,530
Finance costs	(491)	(1,145)	(1,636)	(519)	(1,151)	(1,670)	(998)	(2,329)	(3,327)
	---------	-----------	---------	---------	-----------	---------	---------	-----------	-----------
Profit/(loss) before taxation	14,448	(73,984)	(59,536)	17,603	173,783	191,386	34,472	198,731	233,203
	---------	----------	---------	---------	----------	---------	---------	----------	---------
Taxation	(1,859)	(133)	(1,992)	(1,662)	(59)	(1,721)	(3,194)	(59)	(3,253)
	---------	-----------	---------	---------	-----------	---------	---------	----------	---------
Profit/(loss) for the period	12,589	(74,117)	(61,528)	15,941	173,724	189,665	31,278	198,672	229,950
	=====	======	======	=====	======	======	======	======	======
Earnings/(loss) per ordinary share(note 3)	1.16p	(6.83p)	(5.67p)	1.31p	14.31p	15.62p	2.63p	16.70p	19.33p
	=====	======	======	=====	======	======	======	======	======

Half-year ended 30 April 2025 (Unaudited)	Called up share capital £'000		Share premium account £'000		Capital redemption reserve £'000		Other capital reserves £'000		Revenue reserve £'000		Total £'000
Total equity at 1 November 2024	32,878		159,797		12,489		1,186,189		42,793		1,434,146
Total comprehensive income:
- Loss for the period	-		-		-		(74,117)		12,589		(61,528)
Transactions with owners, recorded directly to equity:
- Buy-back of shares to treasury (note 5)	-		-		-		(97,117)		-		(97,117)
- Ordinary dividends paid (note 11)	-		-		-		-		(15,203)		(15,203)
	----------		----------		----------		-------------		----------		--------------
Total equity at 30 April 2025	32,878		159,797		12,489		1,014,955		40,179		1,260,298
	======		======		======		========		======		========

Half-year ended 30 April 2024 (Unaudited)	Called up share capital £'000	Share premium account £'000		Capital redemption reserve £'000		Other capital reserves £'000		Revenue reserve £'000		Total £'000
Total equity at 1 November 2023	32,878	159,797		12,489		1,084,848		43,511		1,333,523
Total comprehensive income:
- Profit for the period	-	-		-		173,724		15,941		189,665
Transactions with owners, recorded directly to equity:
- Buy-back of shares to treasury (note 5)	-	-		-		(53,389)		-		(53,389)
- Ordinary dividends paid (note 11)	-	-		-		-		(16,205)		(16,205)
	----------	----------		----------		-------------		----------		--------------
Total equity at 30 April 2024	32,878	159,797		12,489		1,205,183		43,247		1,453,594
	======	======		======		========		======		========


Year ended 31 October 2024 (Audited)	Called up share capital £'000	Share premium account £'000		Capital redemption reserve £'000		Other capital reserves £'000		Revenue reserve £'000		Total £'000
Total equity at 1 November 2023	32,878	159,797		12,489		1,084,848		43,511		1,333,523
Total comprehensive income:
- Profit for the year	-	-		-		198,672		31,278		229,950
Transactions with owners, recorded directly to equity:
- Buy-back of shares to treasury (note 5)	-	-		-		(97,331)				(97,331)
- Ordinary dividends paid (note 11)	-	-		-		-		(31,996)		(31,996)
	----------	----------		-----------		-------------		----------		-------------
Total equity at 31 October 2024	32,878	159,797		12,489		1,186,189		42,793		1,434,146
	======	======		======		========		======		========

	(Unaudited) As at 30 April 2025 £'000	(Unaudited) As at 30 April 2024 £'000	(Audited) As at 31 October 2024 £'000

Non-current assets
Investments held at fair value through profit or loss	1,320,427	1,530,994	1,455,333
	-------------	-------------	-------------

Current assets
Investments held at fair value through profit or loss (note 4)	23,962	21,509	33,549
Other receivables	4,658	7,128	4,646
Cash and cash equivalents	39,175	28,726	66,689
	--------------	--------------	--------------
	67,795	57,363	104,884
	--------------	--------------	--------------
Total assets	1,388,222	1,588,357	1,560,217
	--------------	--------------	--------------
Current liabilities
Other payables	(3,867)	(10,604)	(2,315)
	--------------	--------------	--------------
	(3,867)	(10,604)	(2,315)
	--------------	--------------	--------------
Total assets less current liabilities	1,384,355	1,577,753	1,557,902
	--------------	--------------	--------------
Non-current liabilities
Unsecured loan notes	(124,057)	(124,159)	(123,756)
	--------------	--------------	--------------
Net assets	1,260,298	1,453,594	1,434,146
	========	========	========

Equity attributable to equity shareholders
Share capital (note 5)	32,878	32,878	32,878
Share premium account	159,797	159,797	159,797
Capital redemption reserve	12,489	12,489	12,489
Retained earnings:
Other capital reserves	1,014,955	1,205,183	1,186,189
Revenue reserve	40,179	43,247	42,793
	--------------	--------------	--------------
Total equity	1,260,298	1,453,594	1,434,146
	========	========	========
Net asset value per ordinary share(note 6)	118.5p	122.7p	125.2p
	======	======	======

Reconciliation of profit before taxation to net cash flow from operating activities	(Unaudited) Half-year ended 30 April 2025 £'000	(Unaudited) Half-year ended 30 April 2024 £'000	Restated1 (Audited) Year ended 31 October 2024 £'000
Operating activities
(Loss)/profit before taxation	(59,536)	191,386	233,203
Less: loss/(gain) on investments held at fair value through profit or loss	70,740	(177,057)	(205,394)
Purchases of investments	(458,000)	(353,778)	(1,013,738)
Sales of investments	524,303	428,187	1,191,430
Purchases of current asset investments	(93,533)	(49,907)	(117,393)
Sales of current asset investments	103,120	41,514	96,959
Increase/(decrease) in securities purchased for future settlement	632	13,540	(13,721)
(Increase)/decrease in securities sold for future settlement	-	(6,271)	13,559
(Increase)/decrease in other receivables	(30)	(32)	32
Increase/(decrease) in other payables	73	(104)	(94)
Decrease/(increase) in accrued income	65	(1,651)	502
Add back interest payable ('finance costs')	1,636	1,670	3,327
	------------	------------	------------
Net cash inflow from operating activities before interest and taxation	89,470	87,497	188,672
Interest paid	(1,664)	(2,438)	(3,359)
Taxation paid	(2,038)	(1,706)	(2,932)
	------------	------------	------------
Net cash inflow from operating activities	85,768	83,353	182,381
	=======	=======	=======

Financing activities
Equity dividends paid	(15,203)	(16,205)	(31,996)
Share buy-backs	(96,244)	(53,389)	(98,207)
	------------	------------	------------
Net cash outflow from financing activities	(111,447)	(69,594)	(130,203)
	=======	=======	=======

(Decrease)/increase in cash	(25,679)	13,759	52,178
Cash and cash equivalents at the start of the period	66,689	14,525	14,525
Exchange movements	(1,835)	442	(14)
	-----------	-----------	------------
Cash and cash equivalents at the end of the period	39,175	28,726	66,689
	=======	=======	=======

4.	Current asset investment The Company has a holding in the Deutsche Bank Global Liquidity Series Fund, a money market fund which is viewed as a readily disposable store of value and which is used to invest cash balances that would otherwise be placed on short-term deposit. At 30 April 2025 this holding had a value of £23,962,000 (30 April 2024: £21,509,000; 31 October 2024: £33,549,000).

5.	Share capital
	At 30 April 2025 there were 1,315,102,830 ordinary shares of 2.5p each in issue of which 251,912,008 were held in treasury (with no voting rights) (30 April 2024: 1,315,102,830 of which 130,619,544 were held in treasury; 31 October 2024: 1,315,102,830 of which 169,211,960 were held in treasury). During the half-year ended 30 April 2025, 82,700,048 shares were bought back into treasury at a total cost of £97,117,000 (half year to 30 April 2024: 49,748,991 shares were bought back into treasury at a total cost of £53,389,000; year to 31 October 2024: 88,341,407 shares were bought back in to treasury for a total cost of £97,331,000). Since the period end to 24 June 2025, the Company has bought back 16,648,525 shares for treasury for a total cost of £19,467,000.
6.	Net asset value per ordinary share
	The net asset value per ordinary share is based on the net assets attributable to equity shareholders of £1,260,298,000 (30 April 2024: £1,453,594,000; 31 October 2024: £1,434,146,000) and on 1,063,190,822 (30 April 2024: 1,184,483,286; 31 October 2024: 1,145,890,870) ordinary shares, being the number of ordinary shares in issue with voting rights at the period end. The following table reconciles from the NAV with debt at par to the NAV with debt at fair value. Net asset value ("NAV") with debt at par and at fair value
			30 April 2025		30 April 2024		31 Oct 2024
			£'000		£'000		£'000
	NAV with debt at par (A)		1,260,298		1,453,594		1,434,146
	Add back par value of loan notes		124,057		124,159		123,756
	Less fair value of loan notes		(92,324)		(91,757)		(92,618)
	NAV with debt at fair value (B)		1,292,031		1,485,996		1,465,284

	Ordinary shares in issue (C)		1,063,190,822		1,184,483,286		1,145,890,870

	NAV per ordinary share with debt at par (A/C x 100) (pence)		118.5		122.7		125.2
	NAV per ordinary share with debt at fair value (B/C x 100) (pence)		121.5		125.5		127.9

7.	Related party transactions
	The Company's transactions with related parties during the period were with its Directors and Janus Henderson. There have been no material transactions between the Company and its Directors during the period other than the amounts paid to them in respect of Directors' remuneration for which there were no outstanding amounts payable at the period end. In relation to the provision of services by Janus Henderson, other than fees payable by the Company in the ordinary course of business and the provision of marketing services, there have been no transactions with Janus Henderson affecting the financial position or performance of the Company during the period under review.
8.	Financial instruments
	At the period end the carrying value of financial assets approximates their fair value. Financial instruments carried at fair value Fair value hierarchy The unsecured loan notes are valued at par in the Statement of Financial Position. The fair value of the loan notes at 30 April 2025 has been estimated to be £92,324,000 (30 April 2024: £91,757,000; 31 October 2024: £92,618,000) and is categorised as level 3 in the fair value hierarchy as described below. This has been reflected in the daily NAV announcements since January 2024. Previously the unsecured loan notes were valued at amortised cost in the fair value NAV. The following table analyses recurring fair value measurements for financial assets. These fair value measurements are categorised into different levels in the fair value hierarchy based on the inputs to valuation techniques used.

	Financial assets at fair value through profit or loss at 30 April 2025 (Unaudited)	Level 1 £'000		Level 2 £'000		Level 3 £'000		Total £'000
	Investments including derivatives:
	- Equity investments	1,320,427		-		-		1,320,427
	- Fixed interest investments	-		-		-		-
	- Current asset investments	23,962		-		-		23,962
		--------------		---------		--------		--------------
	Total financial assets carried at fair value	1,344,389		-		-		1,344,389
		========		=====		=====		========

	Financial assets at fair value through profit or loss at 30 April 2024 (Unaudited)	Level 1 £'000		Level 2 £'000		Level 3 £'000		Total £'000
	Investments including derivatives:
	- Equity investments	1,530,994		-		-		1,530,994
	- Fixed interest investments	-		-		-		-
	- Current asset investments	21,509		-		-		21,509
		--------------		---------		--------		--------------
	Total financial assets carried at fair value	1,552,503		-		-		1,552,503
		========		=====		====		========

	Financial assets at fair value through profit or loss at 31 October 2024 (Unaudited)	Level 1 £'000		Level 2 £'000		Level 3 £'000		Total £'000
	Investments including derivatives:
	- Equity investments	1,455,333		-		-		1,455,333
	- Fixed interest investments	-		-		-		-
	- Current asset investments	33,549		-		-		33,549
		--------------		---------		--------		--------------
	Total financial assets carried at fair value	1,488,882		-		-		1,488,882
		========		=====		====		========

Rank 30 Apr 2025	Rank 31 Oct 2024	Company	Country	Valuation 31 Oct 2024 £'000	Purchases £'000	Sales proceeds £'000	Appreciation/ (depreciation) £'000	Valuation 30 Apr 2025 £'000
1	1	Microsoft	US	65,307	16,451	(9,586)	(6,377)	65,795
2	5	Alphabet	US	27,066	19,084	(1,683)	(5,821)	38,646
3	4	Broadcom	US	28,032	9,158	(1,463)	2,867	38,594
4	3	Amazon	US	35,436	10,568	(6,413)	(2,614)	36,977
5	2	Apple	US	46,595	12,592	(18,723)	(4,842)	35,622
6	11	Meta	US	23,260	12,931	(3,585)	(2,946)	29,660
7	29	Eli Lilly	US	17,064	10,956	(1,080)	1,234	28,174
8	6	KLA Corp	US	26,961	5,667	(5,792)	522	27,358
9	8	Visa	US	25,759	6,978	(9,773)	3,869	26,833
10	10	American Express	US	23,729	6,701	(2,086)	(2,227)	26,117
11	40	Philip Morris International	US	14,707	7,396	(1,316)	5,243	26,030
12	21	Morgan Stanley	US	19,775	7,561	(1,333)	(1,408)	24,595
13	43	Amphenol	US	14,164	6,470	(765)	1,499	21,368
14	#	JPMorgan Chase	US	-	23,520	(945)	(1,626)	20,949
15	12	Chevron	US	22,799	6,182	(5,958)	(2,866)	20,157
16	#	Intuit	US	9,968	11,354	(894)	(712)	19,716
17	14	Siemens	Germany	22,118	-	(5,308)	2,794	19,604
18	36	Johnson & Johnson	US	15,622	5,551	(1,026)	(1,083)	19,064
19	24	Deutsche Boerse	Germany	18,149	-	(4,180)	4,772	18,741
20	27	Prologis	US	17,850	4,585	(1,187)	(2,903)	18,345
21	7	CME	US	26,908	7,276	(20,132)	3,569	17,621
22	41	Verizon Communications	US	14,696	6,587	(3,455)	(221)	17,607
23	18	National Grid	UK	20,462	-	(4,595)	1,736	17,603
24	44	Raytheon Technologies	US	13,998	3,878	(682)	80	17,274
25	31	NatWest	UK	16,742	-	(4,181)	4,321	16,882
26	34	Marriott International	US	16,018	5,862	(2,950)	(2,849)	16,081
27	39	Stryker	US	14,718	2,376	(1,465)	34	15,663
28	#	Booz Allen Hamilton	US	10,756	11,323	(603)	(5,944)	15,532
29	28	Accenture	US	17,249	7,620	(7,179)	(2,310)	15,380
Rank 30 Apr 2025	Rank 31 Oct 2024	Company	Country	Valuation 31 Oct 2024 £'000	Purchases £'000	Sales proceeds £'000	Appreciation/ (depreciation) £'000	Valuation 30 Apr 2025 £'000
30	#	Walt Disney	US	-	20,126	(601)	(4,197)	15,328
31	#	Progressive	US	-	14,450	(635)	1,366	15,181
32	#	Eaton	US	10,586	7,810	(435)	(2,792)	15,169
33	22	UniCredit	Italy	18,904	-	(7,181)	3,176	14,899
34	#	Dell Technologies	US	7,303	14,634	(580)	(6,597)	14,760
35	25	Oracle	US	18,142	5,593	(4,679)	(4,328)	14,728
36	33	Roche	Switzerland	16,287	1,890	(3,453)	(86)	14,638
37	19	SGS	Switzerland	20,297	-	(3,818)	(1,983)	14,496
38	9	UnitedHealth	US	25,474	3,887	(7,972)	(6,919)	14,470
39	15	Compass	UK	21,843	-	(8,503)	791	14,131
40	#	Salesforce	US	-	18,037	(643)	(3,558)	13,836
41	20	TotalEnergies	France	19,844	-	(4,148)	(1,871)	13,825
42	#	Trane Technologies	US	9,275	5,518	(532)	(500)	13,761
43	26	Hermès	France	18,123	-	(7,482)	3,003	13,644
44	#	Union Pacific	US	-	16,698	(531)	(2,942)	13,225
45	42	Safran	France	14,233	-	(3,429)	1,631	12,435
46	35	Sanofi	France	15,978	-	(3,342)	(301)	12,335
47	#	Vertex Pharmaceuticals	US	11,013	4,571	(3,897)	515	12,202
48	#	Sony	Japan	11,814	439	(4,681)	4,538	12,110
49	32	Informa	UK	16,585	-	(3,896)	(1,129)	11,560
50	48	SAP	Germany	12,324	-	(3,039)	2,184	11,469
				893,933	342,280	(201,815)	(34,208)	1,000,190